CIRCULATING TUMOR DNA BASED DECISION FOR ADJUVANT TREATMENT IN COLON CANCER STAGE II

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
The objective of CIRCULATE trial is to improve care of patients after colon tumor surgery, based on an innovative marker: circulating tumor DNA.
Epistemonikos ID: ebc095f11228858b14e69c9b6842af79b8e638ef
First added on: May 22, 2024